Clinical Trials · NCT04196231
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Enrollment
- 258
- Start date
- Nov 2019
- Locations
- 1 site, Italy
- Primary endpoint
- Hba1c change